IP Library › Patent Application 19283634
Patent Application
App. No. 19/283,634

METHODS AND SYSTEMS FOR SEQUENCING POLYNUCLEOTIDES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/283,634
Abstract

The present disclosure relates generally to detection on non-coding RNAS molecules in a sample or diagnosis of subject based upon detection or quantification of non-coding nucleic acid sequences in a sample, specifically to identify and use of molecular biomarkers for cancer including breast cancer.

Claims (28)

1 . A method for sequencing a ribonucleic acid, comprising:

(a) providing the ribonucleic acid sequence or a functional fragment thereof;

(b) subjecting the ribonucleic acid or the functional fragment thereof to reverse transcription using a reverse transcriptase and a primer to generate a complementary deoxyribonucleic acid (cDNA) molecule, wherein the cDNA molecule comprises a sequence corresponding to a target sequence of the ribonucleic acid or the functional fragment thereof;

(c) amplifying the ribonucleic acid or the functional fragment thereof using one or more probes having different single stranded versus double stranded character; and

(d) sequencing the cDNA molecule or a derivative thereof.

2 . The method of claim 1 , wherein the ribonucleic acid sequence or the functional fragment thereof has a length of less than about 200 nucleotides.

3 . The method of claim 1 , wherein the ribonucleic acid sequence or the functional fragment thereof has a length of less between 50 and 100 nucleotides.

4 . The method of claim 1 , further comprising, after (b), amplifying the cDNA molecule.

5 . The method of claim 1 , wherein (c) comprises a Polymerase Chain Reaction (PCR).

6 . The method of claim 1 , wherein (c) occurs subsequent to (b).

7 . The method of claim 1 , wherein (c) comprises rolling circle amplification.

8 . The method of claim 1 , wherein (c) comprises a ligase chain reaction, multiplex ligatable probe amplification, in vitro transcription (IVT), strand displacement amplification, transcription-mediated amplification, or RNA (Eberwine) amplification.

9 . A reaction mixture, comprising:

a ribonucleic acid sequence or a functional fragment thereof;

one or more probes having different single stranded versus double stranded character for amplification of the ribonucleic acid or the functional fragment thereof;

a reverse transcriptase;

one or more primers; and

a complementary deoxyribonucleic acid molecule wherein the cDNA molecule comprises a sequence corresponding to a target sequence of the ribonucleic acid or the functional fragment thereof.

10 . The reaction mixture of claim 9 , wherein the ribonucleic acid sequence or the functional fragment thereof has a length of less than about 200 nucleotides.

11 . The reaction mixture of claim 9 , wherein the ribonucleic acid sequence or the functional fragment thereof has a length of less between 50 and 100 nucleotides.

12 . The reaction mixture of claim 9 , further comprising a single stranded oligonucleotide containing one or more universal primer sequences.

13 . The reaction mixture of claim 9 , further comprising one or more polyadenylated sequences.

14 . The reaction mixture of claim 9 , further comprising one or more adapter sequences.

15 . The reaction mixture of claim 9 , wherein the one or more primers comprises a primer complementary to a universal primer sequence.

16 . The reaction mixture of claim 9 , wherein the one or more primers comprises a poly(T) primer.

17 . The reaction mixture of claim 16 , wherein the one or more primers comprises a primer complementary to an adapter sequence of the one or more adapter sequences.

18 . The reaction mixture of claim 9 , wherein the one or more primers comprises an amplification primer that specifically binds to the ribonucleic acid or the functional fragment thereof.

19 . The reaction mixture of claim 9 , wherein the one or more primers comprises a reverse transcription primer.